Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

被引:0
|
作者
Amelie Burghardt
Frank van Buuren
Zisis Dimitriadis
Tim Grübbel
Hubert Seggewiss
Smita Scholtz
Dieter Horstkotte
Lothar Faber
机构
[1] Ruhr-Universität Bochum,Clinic for Cardiology, Herz
[2] Leopoldina Hospital, und Diabeteszentrum NRW
来源
关键词
Hypertrophic obstructive cardiomyopathy; HOCM; ICD; Left ventricular outflow tract gradient; Percutaneous septal ablation; Sudden cardiac death;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:479 / 486
页数:7
相关论文
共 50 条
  • [41] Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
    Qin, JX
    Shiota, T
    Lever, HM
    Kapadia, SR
    Sitges, M
    Rubin, DN
    Bauer, F
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Martin, M
    Tuzcu, EM
    Smedira, NG
    Lytle, B
    Thomas, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 1994 - 2000
  • [42] Alcohol septal ablation in hypertrophic obstructive cardiomyopathy
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Wang, Zuyue
    Lindsay, Joseph
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (01) : 72 - 74
  • [43] Age related acute results of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    Faber, L
    Ziemssen, P
    Meyners, W
    Krater, L
    Meissner, A
    Schlichting, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 188A - 188A
  • [44] Alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Knight, Charles J.
    HEART, 2006, 92 (09) : 1339 - 1344
  • [45] Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
    Almeida, Dirceu Rodrigues
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2019, 112 (04) : 439 - 440
  • [46] Telecardiology in the monitoring after percutaneous alcohol septal ablation of obstructive hypertrophic cardiomyopathy
    Moltrasio, M
    Cozzi, S
    Berna, G
    Galli, S
    Doria, E
    Polvani, GL
    Famoso, G
    Borghini, E
    Fassini, G
    Bartorelli, AL
    HEART DISEASE: NEW TRENDS IN RESEARCH, DIAGNOSIS AND TREATMENT, 2001, : 479 - 482
  • [47] Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    EUROPEAN HEART JOURNAL, 2000, 21 (09) : 704 - 707
  • [48] Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
    El Masry, Hicham
    Breall, Jeffrey A.
    CURRENT CARDIOLOGY REVIEWS, 2008, 4 (03) : 193 - 197
  • [49] Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
    Rigopoulos, Angelos G.
    Panou, Fotios
    Kremastinos, Dimitrios Th.
    Seggewiss, Hubert
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (06) : 511 - 522
  • [50] The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Klopotowski, Mariusz
    Chojnowska, Lidia
    Malek, Lukasz A.
    Maczynska, Renata
    Kukula, Krzysztof
    Demkow, Marcin
    Witkowski, Adam
    Dabrowski, Maciej
    Karcz, Maciej
    Baranowski, Rafal
    Kusmierczyk-Droszcz, Beata
    Kruk, Mariusz
    Jamiolkowski, Jacek
    Kusmierczyk, Mariusz
    Szumowski, Lukasz
    Ruzyllo, Witold
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (05) : 285 - 292